Skip to content

Advertisement

  • Poster presentation
  • Open Access

Application of Chromosomal Microarray and Multiplex Ligation-dependent Probe Amplification in prenatal diagnosis

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 2 and
  • 2
Molecular Cytogenetics20147(Suppl 1):P127

https://doi.org/10.1186/1755-8166-7-S1-P127

Published: 21 January 2014

Keywords

  • Genetic Counseling
  • Copy Number Variation
  • Prenatal Diagnosis
  • Intellectual Disability
  • Cost Effective Technique

Background

Chromosomal Microarray (CMA) and Multiplex Ligation-dependent Probe Amplification (MLPA) are relatively newer techniques for detecting cryptic copy number variations (CNVs). Here we are presenting the data of eight families where CMA and MLPA were used for prenatal diagnosis (PND) in view of their previous child with Intellectual disability/ developmental delay (ID/DD) and normal karyotype.

Methods

Families with ID/DD children were referred for genetic counseling in Genetics Clinic, Department of Pediatrics, AIIMS. CNVs were studied in the probands using Illumina Cyto-SNP12 chips and MLPA kits for subtelomeric screening and microdeletion syndrome (P036 and P064) and PND by chorionic villus biopsy or amniotic fluid was performed in cases with pathogenic CNVs.

Results

In eight families, CNVs of clear pathogenic significance were identified using CMA and confirmed by MLPA in seven cases. The probands had 2q32.3q33.3, 22q11.2, deletion in interstitial region while subtelomeric CNVs were 9q34 deletion, 8p deletion and 12p duplication, 5p deletion and 8q duplication in two affected sibs, 7q deletion and 10q duplication, 5p deletion and 6q duplication, 7q deletion and 20p duplication respectively. PND by MLPA (six cases) and CMA(two cases) were done. In six cases, fetus was found to be normal. In one case fetus had 8p deletion and 12p duplication while in another, the fetus had 6q deletion and 5p duplication.

Discussion

CMA and MLPA have clearly demonstrated an increased resolution and improved detection rate of CNVs. CMA detects CNVs across the genome at high resolution enabling precise breakpoints of the CNVs. MLPA is a cost effective technique for developing countries but only limited (upto 45) nucleic acid targets in the genome can be investigated. In our settings it is an efficient technique for confirmation of CNVs and PND.

Authors’ Affiliations

(1)
Genetics Unit, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
(2)
Department of Obstetrics & Gynecology, All India Institute of Medical Sciences, New Delhi, India

Copyright

© Sharma et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement